登录

Fourier Intelligence Raises RMB 100M in Series C Financing

作者: Mailman 2020-10-27 17:20
傅利叶智能
http://www.fftai.com
企业数据由 动脉橙 提供支持
智能机器人开发商 | E轮 | 运营中
中国-上海
2024-01-10
红杉资本中国基金
查看

Fourier Intelligence, a Shanghai, China-based rehabilitation robotic system provider, completed its RMB 100M Series C financing round.


The round was led by Vision Plus Capital, with Qianhai FOF, a urrent shareholder, co-investing in this round as well.


The company intends to use the funds to further expand its product line, to enhance its fully integrated intelligent rehabilitation robotic system, known as the Fourier Intelligence RehabHubTM Concept.


Led by Founder, Group CEO and Executive Chairman Alex Gu, and Co-Founder, Group Deputy CEO, and Chief Strategy Officer, Zen Koh, Fourier Intelligence is an innovative global technology company dedicated to researching, manufacturing, and marketing of rehabilitation robotics and comprehensive intelligent solutions.


The company has offices in Singapore, Malaysia, Guangzhou and Zhuhai.


>>>>

About Vision Plus Capital


Vision Plus Capital was founded in 2015. The team members consist of founding members and senior executives from first-class Internet companies with seasoned operational experience and experienced investors of top tier venture capital firms. Together, we provide hands-on experience and support for start-ups.


相关赛道 医疗机器人
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

东方启音出席哈佛-深圳自闭症国际高峰论坛,展现OST-STAR疗法最新进展

2020-10-27
下一篇

医健地标城市如何打造,宁波有话说!

2020-10-27